These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 26585090

  • 1. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A, Forsaa EB, Pedersen KF, Tysnes OB, Larsen JP, Alves G.
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [Abstract] [Full Text] [Related]

  • 2. Motor complications in an incident Parkinson's disease cohort.
    Scott NW, Macleod AD, Counsell CE.
    Eur J Neurol; 2016 Feb; 23(2):304-12. PubMed ID: 26074125
    [Abstract] [Full Text] [Related]

  • 3. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A.
    Parkinsonism Relat Disord; 2005 May; 11(3):151-5. PubMed ID: 15823479
    [Abstract] [Full Text] [Related]

  • 4. Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease.
    Haaxma CA, Horstink MW, Zijlmans JC, Lemmens WA, Bloem BR, Borm GF.
    J Parkinsons Dis; 2015 May; 5(4):847-53. PubMed ID: 26444087
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 7. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.
    Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G.
    Brain; 2014 Oct; 137(Pt 10):2731-42. PubMed ID: 25034897
    [Abstract] [Full Text] [Related]

  • 8. Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort.
    Kim HJ, Mason S, Foltynie T, Winder-Rhodes S, Barker RA, Williams-Gray CH.
    Mov Disord; 2020 Jan; 35(1):185-190. PubMed ID: 31965629
    [Abstract] [Full Text] [Related]

  • 9. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA, McDermott MP, Messing S.
    Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
    [Abstract] [Full Text] [Related]

  • 10. Motor fluctuations and dyskinesia in Parkinson's disease.
    Nutt JG.
    Parkinsonism Relat Disord; 2001 Oct; 8(2):101-8. PubMed ID: 11489675
    [Abstract] [Full Text] [Related]

  • 11. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
    Schrag A, Quinn N.
    Brain; 2000 Nov; 123 ( Pt 11)():2297-305. PubMed ID: 11050029
    [Abstract] [Full Text] [Related]

  • 12. [Incidence and determinants of levodopa-induced dyskinesia in a retrospective cohort of Mexican patients with Parkinson's disease].
    Cervantes-Arriaga A, Rodríguez-Violante M, Salmerón-Mercado M, Calleja-Castillo J, Corona T, Yescas P, Alonso-Vilatela E.
    Rev Invest Clin; 2012 Nov; 64(3):220-6. PubMed ID: 23045943
    [Abstract] [Full Text] [Related]

  • 13. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [Abstract] [Full Text] [Related]

  • 14. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [Abstract] [Full Text] [Related]

  • 15. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel.
    Marano M, Naranian T, di Biase L, Di Santo A, Poon YY, Arca R, Cossu G, Marano P, Di Lazzaro V, Fasano A.
    Parkinsonism Relat Disord; 2019 Dec; 69():140-146. PubMed ID: 31759188
    [Abstract] [Full Text] [Related]

  • 16. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P.
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [Abstract] [Full Text] [Related]

  • 17. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F, Lilliu H, Le Pen C.
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [Abstract] [Full Text] [Related]

  • 18. Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
    Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, Klein JC, Ben-Shlomo Y, Hu MT.
    Mov Disord; 2019 Aug; 34(8):1174-1183. PubMed ID: 31283854
    [Abstract] [Full Text] [Related]

  • 19. [Motor fluctuations and dyskinesias in Parkinson's disease: variables that discriminate both complications in a sample of 285 patients].
    Gómez JC, Rouco I, Velasco F, Tijero B, Garamendi I, Lezcano E, Zarranz JJ.
    Neurologia; 2008 Oct; 23(8):494-8. PubMed ID: 18770057
    [Abstract] [Full Text] [Related]

  • 20. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.